STAT+: Abridge CEO downplays impact of Epic\u2019s new AI on call with customers
\n \t
\n
<\/BR>
\n
\n \t
\n
<\/BR><\/p>\n
Artificial intelligence company Abridge held a meeting with hospital customers on Thursday to address \u201cconfusion\u201d about how it may be impacted by new AI products coming to Epic Systems\u2019<\/a> widely used electronic health record software.\u00a0<\/p>\n At its annual customer meeting last week, Epic announced that by early next year, it would release a Microsoft-powered AI feature to help doctors draft clinical notes. The product seems to directly compete with Abridge, which sells an AI scribe that\u2019s used by nearly 200 health systems.\u00a0<\/p>\n Abridge has raised over $700 million from investors at a $5 billion valuation<\/a> on the back of this momentum. But Epic controls over 40% of the hospital EHR market, including many of Abridge\u2019s most important customers, and it\u2019s possible the EHR giant\u2019s aggressive move into AI will take a chunk of the market.<\/p>\n Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n